FIELD: medicine. SUBSTANCE: method involves injecting embryonic fibroblasts suspension in the amount of 1 mln of cells per 1 ml into the pleural cavity every 3-5 days. EFFECT: enhanced effectiveness of treatment; stimulated fibroplastic process; prevented empyema occurrence. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR FILLING IN PLEURAL CAVITY AFTER PULMONECTOMY | 2005 |
|
RU2295921C1 |
METHOD OF TREATING DRY RESIDUAL CAVITY AFTER PULMONARY ABSCESS | 1996 |
|
RU2127114C1 |
METHOD OF TREATING ACUTE INFECTION DESTRUCTIONS OF LUNGS AND PLEURA | 1999 |
|
RU2162350C1 |
METHOD FOR TRANSPLANTING FIBROBLASTS INTO RESIDUAL CAVITY | 1996 |
|
RU2130288C1 |
METHOD FOR TREATING RESTRICTED PLEUROPULMONARY CAVITIES | 1998 |
|
RU2154995C1 |
METHOD FOR SETTING EARLY STAGE TUBERCULOSIS EMPYEMA DIAGNOSIS IN PHTHISIOSURGICAL PATIENTS | 2002 |
|
RU2236014C2 |
METHOD FOR PROPHYLAXIS OF POSTPNEUMOECTOMIC PYOTHORAX | 1992 |
|
RU2065726C1 |
METHOD FOR LIMITED CHRONIC PLEURAL EMPYEMA SIMULATION | 2016 |
|
RU2636177C1 |
METHOD OF SANITATION OF INFECTED PLEURAL CAVITY AFTER PNEUMOECTOMY | 1991 |
|
RU2026087C1 |
METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 |
|
RU2161335C2 |
Authors
Dates
2001-07-10—Published
1999-07-15—Filed